Fundraising FoxArtis Ventures — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.
AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US
Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)inNick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))in
BoardGEOFFREY GLASS(Director)inDAVID JOHNSTON(Director)BARY BAILEY(Director)
Co-investorsAbstract VenturesHemisphere Ventures LLCDomain AssociatesLongitude CapitalStarlight VenturesTencent Holdings
Slope provides software to manage the biospecimen lifecycle in clinical trials, giving research sites, sponsors, CROs, and labs oversight of clinical sample inventory and real-time data.
Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSMobile, US
Rust Felix(Chief Executive Officer and Co-founder)inJonathan Rust Felix(Executive Officer, Director)Michael Felix(Executive Officer, Director)
Co-investorsAlumni VenturesBasis Set VenturesBreyer CapitalDynamo VenturesEniac VenturesHigh Country Impact Fund+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.